Literature DB >> 10353253

Histamine, polyamines, and cancer.

M A Medina1, A R Quesada, I Núñez de Castro, F Sánchez-Jiménez.   

Abstract

Mammalian ornithine decarboxylase and histidine decarboxylase present common structural and functional features, and their products also share pharmacological and physiological properties. Although accumulated evidence pointed for years to a direct involvement of polyamines and histamine in tumour growth, it has been only in the last few years that new molecular data have contributed to the clarification of this topic. The aim of this commentary is to review the molecular grounds of the role of histamine and polyamines in cancer and to point to possible directions for future research in emerging areas of interest.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10353253     DOI: 10.1016/s0006-2952(99)00005-2

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  25 in total

1.  Antihistamine use and immunoglobulin E levels in glioma risk and prognosis.

Authors:  E Susan Amirian; Deborah Marquez-Do; Melissa L Bondy; Michael E Scheurer
Journal:  Cancer Epidemiol       Date:  2013-08-30       Impact factor: 2.984

2.  Histamine induces upregulated expression of histamine receptors and increases release of inflammatory mediators from microglia.

Authors:  Hongquan Dong; Wei Zhang; Xiaoning Zeng; Gang Hu; Huiwen Zhang; Shaoheng He; Shu Zhang
Journal:  Mol Neurobiol       Date:  2014-04-22       Impact factor: 5.590

3.  Bile acid increases expression of the histamine-producing enzyme, histidine decarboxylase, in gastric cells.

Authors:  Hye Jin Ku; Hye Young Kim; Hyeong Hoe Kim; Hee Ju Park; Jae Hun Cheong
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

Review 4.  Histamine receptors and cancer pharmacology: an update.

Authors:  Noelia A Massari; Melisa B Nicoud; Vanina A Medina
Journal:  Br J Pharmacol       Date:  2018-12-13       Impact factor: 8.739

5.  The immune microenvironment of myeloma.

Authors:  Kimberly Noonan; Ivan Borrello
Journal:  Cancer Microenviron       Date:  2011-08-25

6.  Serum histamine and acetylcholine variations as new noninvasive biochemical markers in staging of experimental hepatocellular carcinoma.

Authors:  Nabil M Abdel-Hamid; Amer Hasan Abdullah
Journal:  Clin Exp Med       Date:  2018-11-20       Impact factor: 3.984

7.  Metabolomics of biomarker discovery in ovarian cancer: a systematic review of the current literature.

Authors:  Onur Turkoglu; Amna Zeb; Stewart Graham; Thomas Szyperski; J Brian Szender; Kunle Odunsi; Ray Bahado-Singh
Journal:  Metabolomics       Date:  2016-03-08       Impact factor: 4.290

8.  Quantitative expression analysis and prognostic significance of L-DOPA decarboxylase in colorectal adenocarcinoma.

Authors:  C K Kontos; I N Papadopoulos; E G Fragoulis; A Scorilas
Journal:  Br J Cancer       Date:  2010-04-27       Impact factor: 7.640

9.  Coordination Reactions and Noncovalent Interactions of Polyamines with Nucleotides in Binary Systems and with Nucleotides and Copper(II) Ion in Ternary Systems.

Authors:  Lechoslaw Lomozik; Anna Gasowska; Grzegorz Krzysko; Romualda Bregier-Jarzebowska
Journal:  Bioinorg Chem Appl       Date:  2010-09-05       Impact factor: 7.778

10.  Critical factors determining dimerization of human antizyme inhibitor.

Authors:  Kuo-Liang Su; Ya-Fan Liao; Hui-Chih Hung; Guang-Yaw Liu
Journal:  J Biol Chem       Date:  2009-07-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.